Literature DB >> 7088145

Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody-ricin conjugate.

P E Thorpe, D W Mason, A N Brown, S J Simmonds, W C Ross, A J Cumber, J A Forrester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7088145     DOI： 10.1038/297594a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Demonstration of ricin within the mammalian para-aortic lymph node. I. Comparison of the localization, after intramuscular injection, with three immunocytochemical methods.

Authors:  G D Griffiths; A G Leith; M D Leek; M A Green
Journal:  Histochem J       Date:  1989-07

2.  Monoclonal antibody L6-daunomycin conjugates constructed to release free drug at the lower pH of tumor tissue.

Authors:  E Lavie; D L Hirschberg; G Schreiber; K Thor; L Hill; I Hellstrom; K E Hellstrom
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 3.  Magnetic separation techniques: their application to medicine.

Authors:  J T Kemshead; J Ugelstad
Journal:  Mol Cell Biochem       Date:  1985-05       Impact factor: 3.396

4.  Is there a role for radioimmunolocalization in diagnosis of intracranial malignancies?: discussion paper.

Authors:  J T Kemshead; D H Jones; A Goldman; R B Richardson; H B Coakham
Journal:  J R Soc Med       Date:  1984-10       Impact factor: 5.344

5.  Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.

Authors:  E S Vitetta; W Cushley; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Selective killing of leukemic cells by merocyanine 540-mediated photosensitization.

Authors:  F Sieber; J L Spivak; A M Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

Review 7.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.